These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4839158)

  • 1. [Experience with a new benzodiazepines derivative: the RO-5-3350 in fundamental functional diseases of the gastrointestinal system].
    Herrerias Gutierrez JM
    Rev Esp Enferm Apar Dig; 1974 May; 43(3):343-8. PubMed ID: 4839158
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical research on the use of a new benzodiazepine (pinazepam) in gastrointestinal psychosomatic diseases].
    Bertoncelli V; Andrei A; Zaccherotti L
    Clin Ter; 1980 Sep; 94(6):641-58. PubMed ID: 7006888
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-instrumental study of the therapeutic action of a new parasymaptholytic].
    Barbara L; Corinaldesi R; Macaluso G; Luchetta L; Ricci P; Casadio R; Miglioli M
    Clin Ter; 1976 Dec; 79(6):523-47. PubMed ID: 12909
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term therapy of gastrointestinal diseases with gastronerton].
    Tolva D; Testaguzza F
    Med Welt; 1980 Feb; 31(6):230-3. PubMed ID: 7366403
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of a new preparation in upper digestive processes].
    Maldonado Eloy-García J; Escalante Llamas A; Ariza Moscoso A; Moreno López JM; Pérez Olivares J
    Rev Esp Enferm Apar Dig; 1974 Apr; 43(1):89-108. PubMed ID: 4840627
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of functional gastroduodenal evacuation disorders with metoclopramide (Paspertin)].
    Schütz E
    Munch Med Wochenschr; 1967 Jun; 109(22):1227-31. PubMed ID: 5631741
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the treatment of prolonged gastrointestinal paralysis].
    Kronberger L
    Dtsch Med J; 1969 Jul; 20(14):459-62. PubMed ID: 5808047
    [No Abstract]   [Full Text] [Related]  

  • 8. [Controlled evaluation of a new synthetic spasmolytic (DA 3177) in/pathology of the digestive system].
    Battocchio F; Negri L; Tacchettti G
    Clin Ter; 1979 Jun; 89(6):601-10. PubMed ID: 397029
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of prifinium bromide in the treatment of pain caused by hypertonia of smooth muscle].
    Scalco GB; Guerrera C; Liboni A; Malin L
    G Clin Med; 1978; 59(9-10):430-42. PubMed ID: 33098
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled clinical study of a new preparation for the treatment of digestive disorders].
    Mereto GC
    Minerva Gastroenterol; 1975; 21(1):31-4. PubMed ID: 1207938
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gastrointestinal diseases. Therapy with Iberogast].
    Bremer W; Fischer F; Nicolay K
    ZFA (Stuttgart); 1983 Oct; 59(30):1706-9. PubMed ID: 6659661
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endoscopic observations in patients with gastroduodenopathies during treatment with a drug association with antivagal and tranquilizing action].
    Mirelli E; Fichera G
    Minerva Med; 1967 Sep; 58(70):2967-81. PubMed ID: 4383245
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electrogastroenterographic control of the digestive effects of N-butyl hyoscine bromide].
    Martin A; Thillier JL; Moline J; Levet E; Quentin JC
    Therapie; 1972; 27(3):457-63. PubMed ID: 4655210
    [No Abstract]   [Full Text] [Related]  

  • 14. New vistas on gastrointestinal motility: from physiology to therapy an international symposium in Rome.
    Currò D; Holzer P
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():1-2. PubMed ID: 18924439
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of prostaglandins on the motor function of the large intestine].
    Shirokova KI; German SV; Kochina EN
    Klin Med (Mosk); 1980 Sep; 58(9):72-5. PubMed ID: 7412198
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride.
    Boeckxstaens GE; Bartelsman JF; Lauwers L; Tytgat GN
    Am J Gastroenterol; 2002 Jan; 97(1):194-7. PubMed ID: 11811166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new concept in the treatment of gastrointestinal diseases--Propulsin. Workshop, Beerse, Belgium, 16 June 1989].
    Internist (Berl); 1989 Sep; 30(9 Suppl):1-15. PubMed ID: 2635703
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of the sympatholytic pyrroxan for activation of intestinal motility after abdominal operations].
    Ostrovskaia MS
    Anesteziol Reanimatol; 1977; (4):87-90. PubMed ID: 931118
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacology of drugs acting on gastrointestinal motility].
    Van Nueten JM; Schuurkes JA
    Z Gastroenterol; 1988 Nov; 26 Suppl 4():4-8. PubMed ID: 3070983
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of the functional disorders and motor disorders of the upper digestive tract with a new pharmacological preparation acting on the brain stem centers].
    Almeida Júnior N
    Hospital (Rio J); 1966 Oct; 70(4):863-82. PubMed ID: 5301842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.